Merck, also known as MSD outside the U.S. and Canada, plans to significantly expand its workforce in India, aiming for around ...

Adobe announced the general availability of Adobe Real-Time CDP Collaboration in the U.S., a new offering that enables advertisers and publishers to tackle a changing advertising landscape. Brands ...

Merck's injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech ...

HYDERABAD, India, Feb 26 (Reuters) - Drugmaker Merck (MRK.N), opens new tab, known as MSD outside of the U.S. and Canada, expects to increase its workforce across its India sites by the end of the ...

The recent funding marks the first investment of U.S. pharma giant Merck Sharp & Dohme (MSD) in a health tech startup in Asia Pacific. (MSD is the brand that Merck uses to operate outside the U.S ...

Epitopea is a transatlantic cancer immunotherapeutics company developing accessible off-the-shelf RNA-based immunotherapies for use in hard-to-treat cancers by targeting a new class of untapped ...

HYDERABAD, India (Reuters) - Drugmaker Merck, known as MSD outside of the U.S. and Canada, expects to increase its workforce across its India sites by the end of the year, a senior company ...

In addition, Neuphoria has a strategic partnership with Merck & Co., Inc. (known as MSD outside the United States and Canada) with two drugs in early-stage clinical trials for the treatment of ...

Merck & Co/MSD has won approval in the US for PD-1 inhibitor Keytruda as a treatment for hepatocellular carcinoma (HCC), the most common form of liver cancer, opening up another front in its ...

Merck shares have been under pressure amid disappointing sales trends for its Gardasil HPV vaccine. The company's broader drug portfolio continues to perform well and is driving a strong earnings ...